Latest Articles

Publication Date
All News Scientific
US strikes Iran to respond to attack on ship that Trump says violated ceasefire - cbs8.com

US strikes Iran to respond to attack on ship that Trump says violated ceasefire cbs8.com

Published: June 26, 2026, 2:29 p.m.
Read Full Article
With Recent Data, HerAnova Lifesciences Makes the Case for Rule-In Endometriosis Test - 360Dx

With Recent Data, HerAnova Lifesciences Makes the Case for Rule-In Endometriosis Test 360Dx

Published: June 26, 2026, 12:52 p.m.
Read Full Article
New health platform aims to catch 130+ diseases doctors may miss — and a period blood test is on the way - MSN

New health platform aims to catch 130+ diseases doctors may miss — and a period blood test is on the way MSN

Published: June 26, 2026, 6 a.m.
Read Full Article
Catheter-Based OCT May Help ID Early Endometrial Cancer - Endocrinology Advisor

Catheter-Based OCT May Help ID Early Endometrial Cancer Endocrinology Advisor

Published: June 25, 2026, 4 a.m.
Read Full Article
Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed? - simplywall.st

Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed? simplywall.st

Published: June 25, 2026, 2:25 a.m.
Read Full Article
4 chilling details about the Taylor Parker case missing from “Maternal Instinct” - Yahoo

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” Yahoo

Published: June 24, 2026, 10:31 p.m.
Read Full Article
Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.
Read Full Article
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - markets.businessinsider.com

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) markets.businessinsider.com

Published: June 24, 2026, 11:25 a.m.
Read Full Article
Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Absci stock surges 24% on positive Phase 1 hair loss drug data Investing.com South Africa

Published: June 24, 2026, 11:14 a.m.
Read Full Article
Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com - Investing.com India

Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com Investing.com India

Published: June 24, 2026, 11:13 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!